Materials and methods
In a randomized, double-blind, placebo-controlled, crossover study, the effect of alfuzosin 10
All 14 enrolled volunteers completed the study. No significant difference in either SBP, DBP, or HR was observed between the placebo and alfuzosin groups at baseline. Alfuzosin did not affect SBP, DBP, or HR. No hypotensive episode (SBP reduction >10%) was recorded during each treatment.
This study shows that alfuzosin 10
Keywords: Alfuzosin, α1-adrenoceptor antagonist, BPH, Young healthy volunteers, Prostatitis, Distal ureteral stones.
a Urology Division, S. Maria Annunziata Hospital, University of Florence, Florence, Italy
b Section of Urology, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
c Section of Geriatrics, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
d Department of Urology, University of Novara, Novara, Italy
© 2006 European Association of Urology, Published by Elsevier B.V.